News and Trends 19 May 2023
Swedish company develops first effective treatment for hypothyroidism
Prolevi Bio has developed a technology intended to help the 10 to 20% of people who don't respond to current…
- Latest Posts
Podcast 19 May 2023
Beyond Biotech podcast 46: International Clinical Trials Day
This week’s podcast is sponsored by Jubilant Biosys. May 20 is International Clinical Trials Day. ECRIN, the European Clinical Research…
News and Trends 19 May 2023
Researchers make cancer weight loss pathway discovery
Nearly half of all cancer patients suffer from excessive weight loss due to the loss of adipose and skeletal muscle…
News and Trends 19 May 2023
Google Cloud adds AI solutions for drug discovery
Google Cloud has announced two new AI-powered life sciences solutions to accelerate drug discovery and precision medicine for biotech companies,…
ADVERTISEMENT
Best in Biotech 18 May 2023
Six women’s health companies you should know about
While sexism exists in all strands of society, where in 2023, women earn 77 cents for every dollar earned by…
News and Trends 18 May 2023
Could a salt flats pigment treat cancer?
Researchers have identified the anti-cancer capacity of a pigment present in the Santa Pola salt flats in eastern Spain. The…
News and Trends 18 May 2023
Industry responds to UK science strategy launch
The UK Health Security Agency’s (UKHSA) has launched a 10-year science strategy, setting out how science can save more lives…
News and Trends 18 May 2023
8 rare diseases selected for gene therapy trial portfolio
The Foundation for the National Institutes of Health (FNIH) says the Accelerating Medicines Partnership Bespoke Gene Therapy Consortium (AMP BGTC)…
News and Trends 18 May 2023
New epilepsy study could lead to new treatment options
The mechanisms underlying the pathogenesis of epilepsy, a neurological disorder characterized by excessive electrical activity in the brain, remain unknown.…
News and Trends 18 May 2023
Sania Therapeutics launches to advance neural circuit dysfunction medicines
Sania Therapeutics, which develops genetic medicines for neural circuit dysfunction, has launched with the unveiling of its platforms at the…
News and Trends 17 May 2023
Diagnosing inflammatory diseases with synthetic peptides
Common inflammatory disorders such as ulcerative colitis and Crohn's disease can be diagnosed or monitored by measuring the protein calprotectin…
News and Trends 17 May 2023
Scribe and Prevail to accelerate CRISPR-based genetic medicines for neurological and neuromuscular diseases
Scribe Therapeutics Inc., a company creating genetic medicines through its CRISPR by Design approach to genetic modification, has announced a…
Best in Biotech 17 May 2023
Six Norwegian companies leading the country’s biotech scene
Best known for its folklore and tales of the Vikings, Norway’s landscape boasts postcard-like islands and the northern lights. In…
Best in Biotech 16 May 2023
Five advancements in brain tumor research over the past year
In 2023, it is estimated that 24,810 adults in the U.S. will be diagnosed with a primary malignant tumor of…
News and Trends 16 May 2023
LabGenius looks to create molecules with huge increase in tumor killing ability
LabGenius, which uses machine learning (ML) for antibody discovery, has presented data in a poster presentation at the Protein Engineering…
News and Trends 16 May 2023
Molsid developing rapid AMR test
Start-up biomed Molsid is developing the first rapid test to detect the potential presence of antimicrobial resistance (AMR) directly in…
ADVERTISEMENT
News and Trends 16 May 2023
SiSaf siRNA therapy gets FDA designations to treat autosomal dominant osteopetrosis
SiSaf Ltd, an RNA delivery and therapeutics company, has announced that SIS-101-ADO, its siRNA therapeutic for patients with autosomal dominant…
News and Trends 16 May 2023
Researchers’ mutation discovery offers new Alzheimer’s hope
Alzheimer's disease (AD) is a progressive neurodegenerative disorder affecting tens of millions of people worldwide, and it is the most…
News and Trends 15 May 2023
New menopause drug gets FDA approval
The U.S. Food and Drug Administration has approved Astellas Pharma's Veozah (fezolinetant), an oral medication for the treatment of moderate…
News and Trends 15 May 2023
Alzheimer’s drugs could result from immune brain cell discovery
A recent study published in Nature Neuroscience indicates that, contrary to common belief, the immune cells of the brain, known…
